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http://dx.doi.org/10.1016/j.stemcr.2016.09.003SUMMARYEmbryoid body (EB) formation and adherent culture (AD) paradigms are equivalently thought to be applicable for neural specification of
human pluripotent stem cells. Here, we report that sonic hedgehog-induced ventral neuroprogenitors under EB conditions are fated to
medial ganglionic eminence (MGE), while the AD cells mostly adopt a floor-plate (FP) fate. The EB-MGE later on differentiates into GABA
and cholinergic neurons, while the AD-FP favors dopaminergic neuron specification. Distinct developmental, metabolic, and adhesion
traits in AD and EB cells may potentially account for their differential patterning potency. Gene targeting combinedwith small-molecule
screening experiments identified that concomitant inhibition of Wnts, STAT3, and p38 pathways (3i) could largely convert FP to MGE
under AD conditions. Thus, differentiation paradigms and signaling regulators can be integrated together to specify distinct neuronal
subtypes for studying and treating related neurological diseases, such as epilepsy, Alzheimer’s disease, and Parkinson’s disease.INTRODUCTION
To fully apply human pluripotent stem cells (hPSCs) to
the study of neural development and disease, it is crucial
to build efficient neural differentiation protocols with tar-
geted regional identity. The embryoid body (EB) formation
and dual-Smad inhibition-based adherent culture (AD) par-
adigms are the twomost frequently applied neural differen-
tiation systems for hPSCs (Chambers et al., 2009; Zhang
et al., 2001). The EB formation method models the gastru-
lation period by suspension of detached hPSCs in the hPSC
culture medium followed by the neural medium for
neural lineage enrichment. The AD paradigm keeps hPSCs
adherent, but triggers neural induction by applying inhib-
itors of both transforming growth factor b (TGF-b) and
bone morphogenetic protein (BMP) signaling pathways.
With the EB protocol, hPSCs have been efficiently
patterned to medial ganglionic eminence (MGE) and
lateral ganglionic eminence (LGE) (Li et al., 2009; Liu
et al., 2013; Ma et al., 2012). Functional basal forebrain
cholinergic neurons and medium spiny g-aminobutyric
acid (GABA) neurons have been efficiently generated
from these regional progenitors, which show remarkable
therapeutic potentials in correcting behavioral abnormal-
ities resembling those of Alzheimer’s disease and Hunting-
ton disease (Liu et al., 2013; Ma et al., 2012; Yue et al.,
2015). hPSCs has also been efficiently differentiated to
floor plate (FP) and thenmidbrain dopamine (DA) neuronsStem Cell R
This is an open access artithrough the AD protocol, and the yielded DA neurons hold
a promising role in correcting the phenotypes of Parkin-
son’s disease (Fasano et al., 2010; Kriks et al., 2011; Stein-
beck et al., 2015).
Although both EB and AD differentiation paradigms
have been reported to be equally efficient in differentiating
certain neuronal subtypes, such as spinal motor neurons
and GABA interneurons (Chen et al., 2014; Du et al.,
2015; Li et al., 2005, 2008; Liu et al., 2013; Maroof et al.,
2013; Qu et al., 2014; Wang et al., 2013; Xu et al., 2016),
it remains unclear whether both EB andADneural differen-
tiation protocols are suitable for specifying all types of
regional progenitors or whether they have any bias. Here,
we systematically compare both protocols and offer a
reproducible way to generate various ventral neuroproge-
nitors and related neuronal subtypes through selection
of appropriate differentiation paradigms and signaling
inhibitors.RESULTS
Both EB and AD Neural Differentiation Paradigms Are
Highly Efficient and Favor Anterior Neural Fates in the
Absence of Exogenous Morphogens
For the EB protocol, hPSC aggregates were suspended
in human embryonic stem cell (hESC) medium (hESCM)
for 4 days to initiate differentiation and then switched toeports j Vol. 7 j 941–954 j November 8, 2016 j ª 2016 The Authors. 941
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the neural induction medium (NIM) for neural lineage
specification (Figure S1A). For the AD protocol, hPSCs
were adherently cultured on Matrigel (or mouse embry-
onic fibroblasts [MEFs]) at low density and hESCM/
NIM (1:1 ratio) was supplied to the cells together with
SB431542 and LDN193189, inhibitors to block TGF-b
and BMP signaling, to trigger neural differentiation (Fig-
ure S1B). As shown in Figures S1C and S1D, both protocols
were highly efficient for neural differentiation of H9 hESCs
as demonstrated by synchronized formation of columnar
neuroepithelia and neurospheres, as well as typical neu-
rons, roughly within 4 weeks. qPCR analyses showed
that neural lineage genes PAX6 and SOX1 were upregu-
lated significantly during differentiation, while mesen-
dodermal genes T (Brachyury), CXCR4, GATA6, SOX17,
MESP1, and EOMES were not present, suggesting the effec-
tiveness of both neural differentiation protocols (Figures
S1E and S1F). Without exogenous morphogen treatment,
neural progenitors specified from both EB and AD para-
digms expressed anterior genes, such as FOXG1, EMX2,
and OTX2, but were completely lacking in PAX7, EN1,
or HOXB4, hallmark genes specific for diencephalon,
midbrain, and hindbrain identities, respectively (Joven
et al., 2013; Simeone, 2002) (Figures S1G and S1H). There-
fore, hPSCs adopt an anterior telencephalic neural fate by
default under both EB and AD conditions.
Efficient Generation of RegionalNeural Progenitors by
Patterning Morphogens with Both EB and AD
Paradigms
The columnar neuroepithelia differentiated from H9
hESCs with either EB or AD paradigms later on retained
PAX6, SOX1, and FOXG1 expression (Figures 1A–1D).
Moreover, these cells completely lacked the expression of
NKX2.1, a specific transcription factor expressed in ventral-
most populations along the neural axis (Sussel et al., 1999;
Xu et al., 2004), suggesting a rostral-dorsal regional identity
being acquired in the absence of exogenous patterning
morphogens under both EB and AD conditions (Figures
1B and 1D). Immunostaining and qPCR analyses showed
that addition of sonic hedgehog (SHH) from day 10 to
day 17 under EB conditions or from day 4 to day 12 under
AD conditions depleted PAX6, while significantly inducing
NKX2.1 expression (Figures 1E–1I). This suggests that
a ventral fate is induced by applying SHH and that
both differentiation protocols are competent for regional
patterning. Upon retinoic acid (RA) treatment, FOXG1
was repressed and HOXB4 was greatly induced in both dif-
ferentiation systems (Figures 1J and 1K), suggesting effi-
cient caudalization. Therefore, hESCs could be patterned
into regional progenitors along both dorsal-ventral (D-V)
and anterior-posterior (A-P) axes with either EB or AD
paradigms.942 Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016SHH InducesDistinctMGEversus FP Fate under EB and
AD Conditions
Notably, the absolute expression levels of FOXG1 in EB
(Figure 1J) and AD (Figure 1K) cells under the control
conditions various significantly. Again, the expression
levels of HOXB4 also showed a big difference after RA
caudalization in EB and AD cells. It is therefore reason-
able to postulate that the EB and AD cells tend to adopt
a telencephalic fate based on the uniform FOXG1 protein
expression, increased mRNA expression levels of FOXG1,
OTX2, and EMX2, and minimal mRNA expression of
PAX7, EN1, or HOXB4 (Figures S1G, S1H, and 1A–1D),
while the EB and AD cells may hold different sensitivities
in response to RA-mediated caudalization (Figures 1J
and 1K).
Regarding D-V patterning, the EB and AD cells also ex-
hibited differential specification tendency. As shown in
Figures 2A–2C, although NKX2.1 was equally expressed
in SHH-patterned progenitors differentiated with both EB
and AD methods, FOXA2 was selectively expressed in AD
but not EB differentiated cells, suggesting that differential
ventral fates were induced. We have previously demon-
strated that under EB conditions, high levels of SHH treat-
ment specifies anMGE fate (Li et al., 2009; Liu et al., 2013).
With the EB paradigm, SHH-patterned cells expressed
SOX1 and FOXG1, confirming a forebrain MGE identity
(Figures 2A and 2C). In contrast, under AD conditions
the FOXA2+ cells did not coexpress SOX1 or FOXG1 (Fig-
ures 2B and 2C), suggesting a non-MGE fate. qPCR data
also confirmed the above expression pattern of SHH-
treated EB and AD cells (Figures 2D–2F). Moreover, SHH-
patterned AD cells expressed much higher levels of EN1,
WNT5A, RAX, and CHL1, representative marker genes
for midbrain and ventral diencephalon (Liu et al., 2000;
Parr et al., 1993; Shimogori et al., 2010), at an expense
of FOXG1 expression as compared to SHH-treated EB cells
(Figure 2F). LHX6 and LHX8, key genes for GABA and
acetylcholine neuronal progenitors developed from MGE
(Flames et al., 2007; Manabe et al., 2005; Zhao et al.,
2003), were highly induced in SHH-ventralized EB cells
(Figure 2G). On the other hand, CTIP2, FOXP2, COUP-
TFII, and ZCCHC12, hallmark genes related to LGE or
caudal ganglionic eminence (Arber et al., 2015; Cambray
et al., 2012), could hardly be identified in SHH-treated
EB cells as revealed by qPCR analysis (Figure 2G). In
contrast, under AD conditions LHX6 and LHX8 were not
expressed in the ventralized AD progenitors (Figure 2H).
All these data support our conclusion that SHH induced
an MGE fate under EB conditions, while a non-MGE fate
will be adopted in SHH-treated AD cells.
During primitive streak formation, FOXA2 is turned on
and specifically expressed in the notochord, FP, and endo-
derm tissues along the longitudinal body axis (Ang et al.,
Figure 1. Neuroectoderm Generated with
Both EB and AD Paradigms Holds Normal
Patterning Potency along the A-P and
D-V Axes
(A–D) Without morphogen treatment,
human neuroectoderm cells will take an
anterior-dorsal fate as demonstrated by
uniform PAX6, SOX1, and FOXG1 expression
in committed regional neuroepithelia under
both EB (day 17) (A) and AD (day 12) (C)
conditions. Insets show Hoechst coun-
terstaining of nuclei. Scale bars, 50 mm.
Graphs (B) and (D) show the percentage of
positive cells in (A) and (C), respectively.
Data are presented as mean ± SEM of three
independent experiments.
(E–G) Confocal images show NKX2.1+/
PAX6 ventral progenitors yielded from
both EB (E) and AD (F) differentiation par-
adigms. Insets show Hoechst counter-
staining of nuclei. Scale bars, 50 mm. Graph
(G) shows the percentage of positive cells in
(E) and (F). Data are presented as mean ±
SEM of three independent experiments.
(H and I) SHH treatment at days 10–17 in
EB (H) or days 4–12 in AD (I) differentiated
cells results in efficient ventralization as
shown by increased NKX2.1, while PAX6
expression is decreased. Data are presented
as mean ± SEM of three independent ex-
periments. Unpaired two-tailed Student’s
t test: *p < 0.05, **p < 0.01.
(J and K) RA treatment at days 10–17 in EB
(J) or days 4–12 in AD (K) differentiated
cells results in efficient caudalization as
shown by increased HOXB4, while FOXG1
expression is decreased. Data are presented
as mean ± SEM of three independent ex-
periments. Unpaired two-tailed Student’s
t test: **p < 0.01.
See also Figure S1.1993; Placzek, 1995; Sasaki and Hogan, 1993). The most
anterior tip of FOXA2-expressing cells is close to the ventral
diencephalon, which also expresses NKX2.1 (Fasano et al.,
2010; Placzek and Briscoe, 2005), while the FP at the
midbrain and hindbrain regions is FOXA2+/NKX2.1. In
an embryonic day 28 (E28) human embryo, the notochordcells were SOX1/PAX6/SOX2 and the FP cells SOX1/
PAX6/SOX2+ (Figure 2I). In an E9.5 mouse embryo, the
entire neural tube, including the roof plate, neuroepithe-
lium, and FP, was SOX2+, while the FOXA2-expressing noto-
chord cells were negative for SOX2 (Figure 2J). The FP cells
uniformly expressed FOXA2 but lacked SOX1 expressionStem Cell Reports j Vol. 7 j 941–954 j November 8, 2016 943
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(Figure2J). Combinedwith these invivo expressiondata, the
AD ventral cells differentiated from hESCs were FOXA2+/
SOX2+/SOX1, proffering an FP fate (Figure 2K). Moreover,
the AD ventral cells differentiated into FOXA2+/TH+ dopa-
mine neurons in a long-term culture, further supporting
their neural and FP identity (Figure 2L). CORIN, another
representative FP characteristic gene, was also highly
expressed in theADventral cells.Moreover, surfactant protein
C (SPC) and thyroglobulin (TG), specific genes for lung and
thyroid (Longmire et al., 2012; Xi et al., 2012), respectively,
were not induced in the SHH-treated AD cells (Figure 2M).
We next repeated the above results in H1 hESC cell line
and a human induced PSC (hiPSC) line (Hu et al., 2010).
Again, SHH-treated EB cells expressed high levels of
FOXG1, SOX1, LHX6, and LHX8, while SHH-treated AD
cells expressed high levels of FOXA2, but almost complete
lack of FOXG1, SOX1, LHX6, or LHX8 expression (Figures
S2A–S2H). Taken together, these observations suggest
that after SHH treatment, hESCs and hiPSCs yield MGE
progenitors under the EB differentiation conditions, while
an FP fate is specified under AD conditions (Figure 2N).
Since these FP progenitors expressed EN1, WNT5A, RAX,
and CHL1, and some of the FOXA2+ cells also double-
positive for NKX2.1 (Figures 2B and 2F), we therefore
hypothesize that these FP progenitors derived under AD
conditions bear a diencephalic or a midbrain regional
identity.Figure 2. SHH Induces Distinct MGE versus FP Ventral Fates unde
(A–C) Confocal images show expression of NKX2.1, SOX1, FOXA2 and
roepithelia after SHH patterning. Insets show Hoechst counterstainin
positive cells in (A) and (B). Data are presented as mean ± SEM of th
**p < 0.01.
(D and E) mRNA expression of SOX1 (D) and FOXA2 (E) in both EB
of SHH exposure. Data are presented as mean ± SEM of three i
**p < 0.01.
(F) In the presence of SHH exposure, cells differentiated under EB or AD
WNT5A, RAX, and CHL1. Data are presented as mean ± SEM of three in
0.05, **p < 0.01.
(G) In EB cells with SHH treatment, neuroprogenitors show high expr
TFII, and ZCCHC12. Data are presented as mean ± SEM of three indepen
(H) LHX6 and LHX8 are highly expressed in EB but not AD differentiat
three independent experiments. Unpaired two-tailed Student’s t test
(I) Confocal images of an E28 human embryo. Human FP cells are posit
(J) Confocal images of an E9.5 mouse embryo. Mouse FP cells uniformly
are positive for FOXA2, but lack SOX1 and SOX2 expression. Scale bar
(K) The FP progenitors generated by SHH exposure under AD conditi
counterstaining of nuclei. Scale bar, 50 mm.
(L) The FP cells specified under AD conditions differentiate into TH+
expression. Scale bar, 50 mm.
(M) FOXA2 and CORIN mRNA is highly induced by SHH exposure unde
presented as mean ± SEM of three independent experiments. Unpaire
(N) Summary of distinct ventral progenitor fates generated under EB
See also Figure S2.TGF-b/BMP Inhibition or Timing of SHH Exposure
Could Not Account for the Variation of EB and AD
Differentiation Paradigms
The aforementioned differences between AD and EB sys-
tems may result from either the application of TGF-b/BMP
inhibitors or the timing of SHH treatment. To test these pos-
sibilities, we removed either LDN193189 or SB431542 from
the AD differentiation system, and results showed that the
majority of the cells remained FOXA2+/NKX2.1+/SOX1
upon SHH patterning, indicating an FP identity (Figures
S3A and S3B). To test whether earlier SHH exposure prefers
to generate FP cells, SHH was added to the EB cells 1, 4, or
10days post differentiation.However, FOXA2 expression re-
mained at low levels in all of these three time sets, although
NKX2.1was equally induced (Figure S3C). Under AD condi-
tions, SHH treatment at days 1, 4, or 7 equally induced an FP
fate, illustrated by concomitant FOXA2 and NKX2.1 induc-
tion (Figure S3D). The AD cells were committed to a dorsal
fate and lost their patterning potency after day 10, since
no FOXA2 or NKX2.1 could be induced at the expense of
PAX6 expression thereafter (Figures S3D and S3E). Together,
these results indicate that the differential potency in MGE
versus FP patterning of EB and AD cells does not result
from TGF-b/BMP inhibition or the timing of SHH exposure.
Both EB (Cunningham et al., 2014; Kim et al., 2014; Liu
et al., 2013) andAD (Maroof et al., 2013) cultures have been
applied for MGE specification from hPSCs. In the study byr EB and AD Conditions
FOXG1 at day 17 in EB (A) or day 12 in AD (B) differentiated neu-
g of nuclei. Scale bars, 50 mm. Graph (C) shows the percentage of
ree independent experiments. Unpaired two-tailed Student’s t test:
and AD differentiated neuroepithelia in the presence or absence
ndependent experiments. Unpaired two-tailed Student’s t test:
conditions show differential mRNA expression levels of FOXG1, EN1,
dependent experiments. Unpaired two-tailed Student’s t test: *p <
ession of LHX6 and LHX8, but no expression of CTIP2, FOXP2, COUP-
dent experiments. Unpaired two-tailed Student’s t test: **p < 0.01.
ed ventral neuroprogenitors. Data are presented as mean ± SEM of
: **p < 0.01.
ive for SOX2, but negative for either PAX6 or SOX1. Scale bar, 50 mm.
express FOXA2 and SOX2, but are negative for SOX1. Notochord cells
, 50 mm.
ons are double-positive for FOXA2 and SOX2. Inset shows Hoechst
neurons after long-term culture, some of which still retain FOXA2
r AD conditions, while SPC and TG can hardly be detected. Data are
d two-tailed Student’s t test: **p < 0.01.
or AD conditions upon SHH treatment.
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Maroof et al. (2013), the AD cells were treatedwithDKK1 to
inhibit Wnts signaling and the cells patterned with SHH
starting from day 10. This seems contradictory to what
we propose above. To address this issue, we took our b-cat-
enin knockout (KO) hESC lines (Chi et al., 2016; Liu et al.,
2016b) and studied their D-V patterning under the AD cul-
ture conditions. Different from thewild-type control, b-cat-
enin KO AD cells at day 10 were efficiently ventralized by
SHH treatment, suggesting that blocking Wnts signaling
extended the efficient patterning window for SHH (Fig-
ure S3F). LHX6 and LHX8were also mildly increased under
the AD culture conditions by SHH treatment in b-catenin
KO hESCs (Figure S3G). Moreover, addition of SHH at a
later time point seems to favor MGE specification because
when SHH was applied to b-catenin KO AD cells at days 4,
7, or 10, the latter yielded a better outcome ofMGE progen-
itors (Figures S3H–S3M). These data indicate that block-
ing Wnts/b-catenin signaling moderately improves MGE
specification, but is not sufficient to completely convert
FP to MGE under AD conditions.
Transcriptional Control of FP and MGE Specification
FP and MGE show differential expression of FOXA2 and
FOXG1, which play essential roles in FP and forebrain
development, respectively. We next asked whether genetic
manipulation of these transcription factors could switch
the FP fate to an MGE identity under AD conditions.
We constructed a FOXG1-inducible overexpression line
(FOXG1-iOE) in hESCs (Figures 3A and 3B). FOXG1-iOE
showed normal D-V patterning in the presence of SHH as
demonstrated by decreased PAX6whileNKX2.1 expression
increased (Figures 3C and 3D). However, overexpression of
FOXG1 could not convert the FP to an MGE fate, since the
cells still showed equally high levels of EN1, FOXA2, and
CORIN expression with relatively low SOX1 expression
(Figures 3E–3H). We then knocked out FOXA2 in hESCs
(Figure 3I). FOXA2 KO cells were similarly patterned
ventrally by SHH (Figures 3J and 3K). Moreover, the ventral
cells still retained an FP-like but non-MGE identity, given
their PAX6/NKX2.1+/SOX1 expression pattern (Figures
3J–3O). In the FOXA2 KO cells, FOXA1 was decreased but
remained at a detectable level (Figure 3P). It remains to be
investigated whether FOXA1 and FOXA2 play redundant
roles in mediating FP development.
Developmental, Metabolic, and Adhesion Properties
Predetermine the FP versus MGE Specification
To delineate the underlying mechanisms guiding FP and
MGE specification, we profiled transcriptomes of early AD
and EB cells destined to undergo distinct ventral fates
before SHH treatment. We first adjusted the differentiation
paradigm and tried to minimize the systematic differences
between AD and EB protocols (Figures S4A and S4B). AD946 Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016cells treated with SB431542 and LDN193189 for 4 days
differentiated into FP, while EB cells treatedwith or without
SB431542 and LDN193189 for 4 days mostly fated to
MGE (Figures S4C and S4D). We therefore chose day-4
EB cells, day-4 EB cells with SB431542 and LDN193189,
and day-4 AD cells with SB431542 and LDN193189 for
mRNA-sequencing analyses (GEO: GSE82052). Through
weighted gene coexpression network analyses (WGCNA)
(Langfelder and Horvath, 2008), we isolated seven inter-
connected gene modules (Figure 4A). Module-trait correla-
tion matrix demonstrated that these gene clusters showed
differential gene expression enriched in either EB cells
(blue and red modules) or AD cells (yellow and green
modules) (Figure 4A). We found a total of roughly 600
genes which were specifically enriched in both day-4 EB
cells and day-4 EB cells treated with SB431542 and
LDN193189 (Figure 4B). Meanwhile, there were around
1,000 genes which showed significantly higher expression
in AD cells (Figure 4B). Gene ontology biological process
term enrichment of differentially expressed genes revealed
that developmental traits, adhesion properties, and meta-
bolic states showed prominent differences in EB and
AD cells. EB cells showed upregulated epithelial genes
including KRT17, ELF3, and POU2F3 (Figure 4C). In
contrast, AD cells expressed high levels of T, TBX15, and
ZIC1, genes expressed at late-stage epiblast or primitive
streak (Figure 4D). Moreover, mesenchymal genes, such
as SNAI2, TWIST1, and TWIST2, were significantly ex-
pressed in AD cells (Figure 4D). EB cells expressed high
levels of tight junction-related genes, while AD cells were
enriched with genes encoding cadherin family proteins
and collagens (Figures 4C and 4D). Meanwhile, EB cell-en-
riched genes were clustered in HIF1a and wound-healing
pathways together with organic substance metabolism.
On the other hand, AD cells showed more robust choles-
terol and zymosterol biosynthesis activities and were also
active in the STAT3 and phosphatidylinositol 3-kinase
(PI3K)/PTEN signaling pathways correlated with nutrient
sensing (Figures 4C–4F). Therefore, complex intracellular
cell contexts and extracellular components work together
and define the distinct differentiation potencies of the
AD and EB cells upon SHH patterning.
Generation of a Floor-Plate Reporter Line by Targeting
of FOXA2
To better monitor the different ventral progenitor fates, we
constructed a FOXA2-2A-EGFP reporter line through ho-
mologous recombination (Figure 5A). The CRISPR/Cas9
system was used to make a double-strand break surround-
ing the stop codon region of FOXA2. Targeting efficiency
of the guide RNA (gRNA) was tested in human embryonic
kidney (HEK) 293FTcells 3 days after transient transfection
of the gRNA and Cas9 vectors (Figure 5B). A homologous
Figure 3. Targeting FOXG1 and FOXA2 Fails to Bring the AD Cells an MGE Identity
(A) Schematic representation of the strategy in construction of FOXG1-iOE hESCs.
(B–H) mRNA levels of FOXG1, PAX6, NKX2.1, EN1, FOXA2, CORIN, and SOX1 in day-12 AD differentiated wild-type (WT) or FOXG1-iOE hESCs
in the absence or presence of SHH. In some groups, doxycycline (Dox) is added to the FOXG1-iOE hESCs to induce exogenous FOXG1
expression. Data are presented as mean ± SEM of three independent experiments. Unpaired two-tailed Student’s t test: *p < 0.05,
**p < 0.01.
(I) Schematic representation of the strategy in construction of FOXA2 KO hESCs.
(J and K) Confocal images show NKX2.1+/SOX1 FP-like cells induced in SHH-treated FOXA2 KO cells under AD conditions. Insets show
Hoechst counterstaining of nuclei. Scale bars, 50 mm.
(L–P) FOXA2, PAX6, NKX2.1, SOX1, and FOXA1 mRNA expression in day-12 AD differentiated wild-type or FOXA2 KO hESCs in the absence or
presence of SHH. Data are presented as mean ± SEM of three independent experiments. Unpaired two-tailed Student’s t test: **p < 0.01.
See also Figure S3.recombination donor plasmid was designed to incorporate
the P2A-EGFP cassette just upstream of the stop codon
and with the puromycin selection gene downstream.
FOXA2-2A-EGFP targeting donor vector, gRNA, and Cas9
expressing vectors were coelectroporated into hESCs and
puromycin-resistant colonies were selected. Retrieved col-onies were then subjected to genomic DNA PCR analyses
by using primer sets specifically targeting the wild-type
allele and the recombined allele. Among the nine colonies
picked up, colonies 1, 2, and 4 represented heterozygotes
(FOXA2EGFP/w), and colonies 5, 6, 8, and 9 represented
homozygotes (FOXA2EGFP/EGFP) (Figure 5C).We then choseStem Cell Reports j Vol. 7 j 941–954 j November 8, 2016 947
Figure 4. Transcriptome Profiling of EB and AD Cells Destined to Ventralize into MGE or FP
(A) WGCNA analyses show isolated interconnected gene modules and module-trait correlation matrix demonstrated gene clusters enriched
in either EB or AD cells.
(B) Heatmap graph shows EB- and AD-enriched genes.
(C–F) Gene ontology (C, D) and ingenuity pathway (E, F) analyses of EB- and AD-enriched genes.colony 1 (FOXA2EGFP/w) for AD differentiation, and SHH
induction initiated GFP expression from day 5. GFP was
uniformly expressed inmost of the cells 12 days post differ-
entiation (Figure 5D). Western blotting analyses further
demonstrated that most of the FOXA2-2A-EGFP fusion
proteins were cleaved into FOXA2 and EGFP, coinciding
with the cytoplasmic expression ofGFP (Figure 5E). Neither
removal of LDN193189 nor removal of SB431542 abro-
gated GFP expression induced by SHH under AD condi-
tions (Figures 5F and 5G), consistent with previous results
(Figure S3). In the SHH-treated EB group, a small popula-
tion of cells were positive for GFP (Figures 5H and 5I), but
these FOXA2+ cells were negative for SOX2 (Figure 5J).948 Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016The FOXA2+/SOX2 cells most likely had a notochord
fate, further supporting the point that FP cells could hardly
be generated under EB conditions. Therefore, the GFP
expression pattern faithfully recapitulates FOXA2 expres-
sion, and the FOXA2EGFP/w line is a reliable reporter system
for human FP under AD conditions.
The STAT3 and p38 MAPK Signaling Pathways Are
Crucial for Floor-Plate Specification
To investigate the underlying mechanisms for proper
MGE and FP specification, we carried out a small-
molecule screening by targeting different signaling path-
ways in FOXA2EGFP/w hESCs. The AD differentiation
Figure 5. Generation of an FP Reporter
Line by Targeting FOXA2
(A) Donor DNA used for homologous
recombination. Locations of primer sets for
genotyping are marked with arrows.
(B) Targeting efficiency of the designed
gRNA is verified in HEK 293FT cells after
transient transfection of the gRNA and Cas9
expression vectors. Sequencing of the PCR-
amplified genomic DNA surrounding the
targeting site identifies overlapped peaks,
which represents non-homologous end-
joining repair after correct DNA targeting.
(C) Genotyping experiments show that
seven out of nine randomly picked hESC
colonies are successfully targeted. C, wild-
type control; F1/R1, primer pair amplifies
wild-type allele; F1/R2, primer pair am-
plifies homologous recombined allele.
(D) The heterozygous FOXA2-2A-eGFP line
(colony #1) shows uniform GFP expression
12 days after SHH exposure with the AD
differentiation paradigm, recapitulating
endogenous FOXA2 expression. Scale bar,
50 mm.
(E) Colonies #3, #4, and #5 are differenti-
ated for 12 days with the AD differentiation
paradigm in the presence or absence of
SHH. FOXA2 (48 kDa) is only expressed in
the SHH-treated groups. FOXA2-2A-eGFP
fusion protein (75 kDa) is expressed in
colonies #4 and #5, and a large population
of FOXA2-2A-eGFP is cleaved at the 2A site
as shown by slightly slower shifting bands
compared with the endogenous FOXA2.
(F and G) Removal of LDN193189 or
SB431542 in the AD differentiation proto-
col does not affect FP specification as
shown by similar GFP expression in a FOXA2-2A-eGFP reporter line induced by SHH. Scale bars, 50 mm.
(H) FOXA2-2A-eGFP reporter line is differentiated under EB conditions for 20 days without extra patterning morphogens. No GFP expression
is observed under the fluorescence microscope. Scale bars, 50 mm.
(I) FOXA2-2A-eGFP reporter line is differentiated under EB conditions for 20 days and SHH is applied from day 10 to day 20. Only a small
population of GFP-positive cells is seen under the fluorescence microscope. Scale bars, 50 mm.
(J) Confocal image shows that the FOXA2-positive cells derived from the EB differentiated cells are SOX2 negative, indicating a notochord
fate rather than FP. Scale bar, 50 mm.
See also Figure S4.paradigm was accommodated to the 48-well culture
plates. In total, 303 stem cell regulators and 80 ki-
nase inhibitors purchased from the National Com-
pound Resource Center (http://www.chemicallibrary.org.
cn/11115.html) were added to the AD FOXA2EGFP/w cells
together with SHH at day 1. Bright-field and GFP images
were taken at day 7 (Figure S5A). Among all the small
molecules, nearly 110 drugs induced cell-growth arrest
or cell death over the first several days. Within the re-
maining 270 drugs, we found seven small moleculesthat significantly repressed GFP intensity during AD dif-
ferentiation. These drugs were cyclopamine (an SHH
inhibitor), SB202190 (a p38 mitogen-activated protein
kinase [MAPK] inhibitor), AG490 (a JAK2-STAT3 inhibi-
tor), DAPT (a Notch inhibitor), ZM336372 (a Raf-1 inhib-
itor), KN62 (a CaMKII inhibitor), and LY294002 (a PI3K
inhibitor). The observation that cyclopamine efficiently
repressed EGFP expression ensured the feasibility of the
current reporter system for signaling screening (Figures
S5B and 5C).Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016 949
Figure 6. The STAT3 and p38 MAPK Signaling Pathways Are Crucial for Floor-Plate Specification
(A and B) Confocal images show expression of FOXA2 (A) and NKX2.1 (B) in day-12 neuroepithelia differentiated under AD conditions in
the presence of SHH and represented signaling inhibitors. Scale bars, 50 mm.
(C and D) FOXA2 (C) and NKX2.1 (D) mRNA expression in day-12 neuroepithelia differentiated under AD conditions in control, SHH, or SHH
plus represented signaling inhibitor groups. Data are presented as mean ± SEM of three independent experiments. Unpaired two-tailed
Student’s t test: **p < 0.01.
(E) Western blot shows temporal activation of STAT3 and p38 MAPK along hESC differentiation under AD or EB conditions.
(F–H) qPCR results show that combined AG490 and SB202190 treatment decreases EN1 and CORIN (F), but increases FOXG1 and SOX1 (G)
and LHX6 and LHX8 (H) expression after SHH exposure. Data are presented as mean ± SEM of three independent experiments. Unpaired two-
tailed Student’s t test: *p < 0.05, **p < 0.01.
See also Figure S5.Immunocytochemistry analysis and qPCR results
confirmed that FOXA2 protein and mRNA levels were
repressed in the presence of all of the above inhibitors (Fig-
ures 6A and 6C). Among these small molecules, KN62 and
LY294002 showed the highest robustness in repression
of FOXA2 (Figures 6A and 6C). Meanwhile, NKX2.1 and
SOX2 were also concomitantly repressed by these two in-
hibitors, suggesting that a non-neural fate was induced
(Figures 6B, 6D, and S5D). Indeed, VEGFR2, a mesodermal
marker, was highly expressed in KN62- or LY294002-
treated cells (Figure S5E). These data indicate that the
CaMKII and PI3K signaling pathways are required for
neural induction. ZM336372 inhibited both FOXA2 and
NKX2.1 expression, while PAX6 was highly expressed950 Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016even under SHH treatment (Figures 6A–6D and S5F). This
suggests that Raf-1 signaling is required for SHH-trig-
gered ventralization. DAPT also repressed both FOXA2
and NKX2.1 (Figures 6A–6D), indicating the involvement
of the Notch pathway in proper FP development. Interest-
ingly, SB202190 and AG490 inhibited FOXA2 but main-
tained NKX2.1 expression (Figures 6A–6D). This indicates
that the activity of p38 MAPK and JAK2-STAT3 signaling
pathways are crucial for FP specification, and blocking
these two pathways could benefit MGE specification under
AD conditions.
To confirm that FP and MGE fates could indeed be
switched over by modulating the activity of p38 MAPK
and JAK2-STAT3, we analyzed whether these pathways
Figure 7. Generation of Distinct
Neuronal Subtypes with AD and EB
Paradigms
(A and B) Without SHH treatment, both
EB and AD anterior-dorsal progenitors
generate TUJ1+/TBR1+ (A) and VGluT1+/
GABA (B) cortical neurons at day 50 post
differentiation. Scale bars, 50 mm.
(C and D) EB-MGE progenitors mostly
generate GABA interneurons (C) and CHAT+
cholinergic neurons (D). AD-FP progenitors
mostly generate TH+ DA neurons (C).
Blocking p38, STAT3, and Wnts pathways
generates more GABA and cholinergic but
fewer DA neurons. Insets show Hoechst
counterstaining of nuclei. Scale bars,
50 mm.
(E–G) Quantification of percentage of pos-
itive GABA (E), TH (F), and CHAT (G) cells in
(C) and (D). Data are presented as mean ±
SEM of three independent experiments.
Unpaired two-tailed Student’s t test: *p <
0.05, **p < 0.01.
(H) Summary of strategies for differenti-
ation of various ventral progenitors and
related neuronal subtypes via EB and AD
differentiation paradigms in combination
with small molecules.
See also Figure S6.were activated during FP specification by western blotting.
As shown in Figure 6E, STAT3 was highly phosphorylated
at the early stage of AD, but not EB, differentiated cells.
The protein expression of total STAT3 and the phos-
phorylated form of STAT3 dramatically decreased upon
RA treatment in hESCs and hiPSCs (Figure S5G). Under
AD conditions, SHH treatment greatly triggered p38 phos-
phorylation at days 7 and 12 post differentiation. These
data strongly suggest that p38 MAPK and JAK2-STAT3
signaling pathways may play important roles in FP specifi-
cation. The differential activation pattern of these two
pathways also suggests that their roles in FP specification
may vary. We next treated the AD cells with both AG490
and SB202190 (hereafter referred to as 2i) from day 1 to
day 12, and SHH was supplied from day 4 to day 12. 2i
administration decreased EN1 and CORINwhile increasing
FOXG1 and SOX1 expression (Figures 6F and 6G). Moreimportantly, LHX6 and LHX8were now expressed at a later
stage (Figure 6H), suggesting that anMGE fate was induced.
Again, the same results were obtained from both H1 hESCs
and hiPSCs (Figures S5H–S5L).
Specification of Different Neuronal Subtypes with AD
and EB Paradigms
During development, MGE progenitors yield GABA inter-
neurons and basal forebrain cholinergic neurons, while the
FP progenitors almost exclusively generate DA neurons. For
terminal neuronal differentiation, we digested neuroproge-
nitors and plated them on laminin precoated coverslips.
After continued differentiation for 4 weeks, TBR1+/VGluT1+
cortical excitatory neurons were generated in both EB and
AD differentiation paradigms without SHH treatment (Fig-
ures 7A and 7B). In vitro generated EB-MGE progenitors
ventralized via SHH treatment differentiated into GABAStem Cell Reports j Vol. 7 j 941–954 j November 8, 2016 951
neurons and CHAT+ cholinergic neurons after continued
differentiation (Figures 7C–7G). In contrast, upon SHH
patterning, the AD-FP progenitors preferentially generated
DAneurons (Figures 7C and 7F). 2i treatment in the AD cells
resulted in the generation of more GABA and CHAT+ neu-
rons and fewer DA neurons, coinciding with an FP to
MGE fate switch (Figures 7C–7G). b-catenin KO or applying
IWP2 to block Wnts signaling behaved similarly to 2i treat-
ment (Figures 7C–7G and S6). Notably, blocking all three
signaling pathways simultaneously (b-catenin KO plus 2i, or
3i) generated amaximumamount ofGABA andCHAT+ neu-
rons of MGE origin, which reached an efficiency of about
60% compared with the EB-MGE cells (Figures 7C–7H
and S6).DISCUSSION
In this study we present evidence and show that hPSCs
mostly adopt a rostral-dorsal identity during in vitro neural
differentiation with both EB and AD paradigms in the
absence of patterning morphogens. SHH patterns in vitro
differentiated human neuroectoderm under both EB and
AD conditions to ventral progenitors, as demonstrated by
a PAX6 to NKX2.1 expression shift. However, differential
ventral fates are acquired in hPSCs under EB versus AD
conditions in response to SHH stimulation (Figure 7H).
An MGE regional fate followed by GABA and cholinergic
neurons will be generated in SHH-treated EB cells, while
ventralized AD cells mostly yield FP progenitors and TH+
neurons. Wnts/b-catenin, STAT3, and p38 pathways are
crucial for proper FP specification, and blocking these path-
ways could largely switch FP to MGE (Figure 7H).
Fetal mesencephalic or striatal tissues have been used as a
source of DA neurons or GABA neurons for transplantation
in clinical trials (Lindvall et al., 1989; Philpott et al., 1997).
These clinical studies raise the hope of curing hitherto
intractable human neurodegenerative diseases through
replacement therapy. Recent advances in targeted differ-
entiation of hPSCs to neuronal subtypes have begun to
confirm their therapeutic potential in epilepsy, Hunting-
ton disease, Parkinson’s disease, and Alzheimer’s disease
(Cunningham et al., 2014; Liu et al., 2013; Ma et al.,
2012; Roy et al., 2006; Yue et al., 2015). Obtaining func-
tional neuronal subtypes is themajor roadblock in regener-
ative medicine for treating these neurological disorders.
Here, we provide a framework for the generation of distinct
ventral neuronal subtypes of either FP or MGE origin
through a combination of differentiation paradigms and
small molecules. These human MGE and FP progenitors
as well as their differentiated progeny will thus serve as
invaluable cellular sources for the study of brain develop-
ment and related diseases.952 Stem Cell Reports j Vol. 7 j 941–954 j November 8, 2016EXPERIMENTAL PROCEDURES
HPSC Culture
hESC lines H1 and H9 (WA 01 and WA09, passages 25–45, WiCell
Agreement No. 14-W0377 and 17-W0044) and hiPSCs were
cultured on a feeder layer of irradiated MEFs as previously
described (Chi et al., 2016; Liu et al., 2016a; Thomson et al.,
1998; Zhang et al., 2010). Cells were expanded every 5 days
through dispase (Gibco, 17105) digestion. The components of
the hESC culturemedium (hESCM) areDMEM/F12, 20% knockout
serum replacer, 13 minimum essential medium non-essential
amino acids solution, 13 L-glutamine solution, 0.1 mM b-mercap-
toethanol, and 4 ng/mL fibroblast growth factor 2.
EB Formation and Neural Differentiation
The detailed procedures of the EB differentiation system were
described previously (Zhang et al., 2001; Zhang and Zhang,
2010). For caudalization, RA (1 mM, Sigma)was added to the neuro-
ectoderm cells from day 10 to day 17. For ventralization, a combi-
nation of SHH (250 ng/mL, R&D Systems) and the smoothened
activator purmorphamine (0.3 mM, Stemgent), a condition referred
to hereafter as SHH, was added to the neuroectoderm cells from
day 10 to day 17.
Dual-Smad Inhibition-Based AD Culture and Neural
Differentiation
The AD differentiation system was modified from the previously
published protocols (Chambers et al., 2009; Xi et al., 2012). hPSCs
at approximately 10% confluence (1 day after passaging) were
cultured in hESCM/NIM (50%:50%) supplied with SB431542
(2 mM, Stemgent) and LDN193189 (200 nM, Stemgent) for the first
7 days. RA or SHH were added to the cells at an indicated time
point after differentiation, or on day 4 after differentiation if not
mentioned specifically.
Statistical Analysis
Data were analyzed using Student’s t test for comparison of inde-
pendent means with pooled estimates of common variances.
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